168 related articles for article (PubMed ID: 37731315)
1. Drug reaction with eosinophilia and systemic symptoms in a paediatric population: Interest of skin tests.
Ben Romdhane H; Fadhel NB; Chadli Z; Chaabane A; Benzarti W; Fredj NB; Aouam K
Contact Dermatitis; 2023 Dec; 89(6):488-495. PubMed ID: 37731315
[TBL] [Abstract][Full Text] [Related]
2. Viral rashes mimicking drug reaction with eosinophilia and systemic symptoms syndrome in children after β-lactams intake: a diagnostic challenge.
Dondi A; Parladori R; Mori F; Liccioli G; Bassi A; Lanari M; Patrizi A; Neri I
Eur J Pediatr; 2021 Jul; 180(7):2327-2332. PubMed ID: 33686529
[TBL] [Abstract][Full Text] [Related]
3. Drug reaction with eosinophilia and systemic symptoms (DRESS): A tertiary care centre retrospective study.
Del Pozzo-Magaña BR; Rieder MJ; Garcia-Bournissen F; Lazo-Langner A
Br J Clin Pharmacol; 2022 Sep; 88(9):4134-4141. PubMed ID: 35421262
[TBL] [Abstract][Full Text] [Related]
4. Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Series of 49 French Pediatric Cases.
Bedouelle E; Ben Said B; Tetart F; Milpied B; Welfringer-Morin A; Maruani A; Catteau B; Dezoteux F; Staumont-Sallé D; Mazereeuw-Hautier J; Abasq C; Chiaverini C; Delaunay J; Mallet S; Sterling B; Puzenat E; Raynal M; Collet E; Bernier C;
J Allergy Clin Immunol Pract; 2022 Jan; 10(1):267-274.e5. PubMed ID: 34332174
[TBL] [Abstract][Full Text] [Related]
5. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature, with a focus on relapsing cases.
Afiouni R; Zeinaty P; Kechichian E; Zoghaib S; Matar S; Helou-Mallat J; Tomb R
Pediatr Dermatol; 2021 Jan; 38(1):125-131. PubMed ID: 33155729
[TBL] [Abstract][Full Text] [Related]
6. Pediatric drug reaction with eosinophilia and systemic symptoms: A systematic review of the literature.
Metterle L; Hatch L; Seminario-Vidal L
Pediatr Dermatol; 2020 Jan; 37(1):124-129. PubMed ID: 31691347
[TBL] [Abstract][Full Text] [Related]
7. Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms (DIHS/DRESS): 11 years retrospective study in Thailand.
Hiransuthikul A; Rattananupong T; Klaewsongkram J; Rerknimitr P; Pongprutthipan M; Ruxrungtham K
Allergol Int; 2016 Oct; 65(4):432-438. PubMed ID: 27134114
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the complexities of drug reaction with eosinophilia and systemic symptoms (DRESS): Insights into clinical, laboratory, and histopathologic features of a case series from an Italian tertiary center.
Schroeder JW; Napoli C; Caputo V; Bonoldi E; Rongioletti F
Clin Dermatol; 2023; 41(6):721-728. PubMed ID: 37730074
[TBL] [Abstract][Full Text] [Related]
9. Patch testing in drug reaction with eosinophilia and systemic symptoms (DRESS): A literature review.
de Groot AC
Contact Dermatitis; 2022 Jun; 86(6):443-479. PubMed ID: 35233782
[TBL] [Abstract][Full Text] [Related]
10. Paediatric case series of drug reaction with eosinophilia and systemic symptoms (DRESS): 12-year experience at a single referral centre in Hong Kong and the first reported use of infliximab.
Chua GT; Rosa Duque JS; Chong PCY; Lee PPW; Lau YL; Ho MHK
Eur Ann Allergy Clin Immunol; 2018 Nov; 50(6):273-276. PubMed ID: 29384118
[TBL] [Abstract][Full Text] [Related]
11. Drug reaction with eosinophilia and systemic symptoms in a cohort of Asian children.
Han XD; Koh MJ; Wong SMY
Pediatr Dermatol; 2019 May; 36(3):324-329. PubMed ID: 30920020
[TBL] [Abstract][Full Text] [Related]
12. Dress syndrome in 7-year-old male child - case report.
Prylińska M; Dworakowska-Kicińska M; Krogulska A
J Mother Child; 2021 Jan; 24(3):45-48. PubMed ID: 33470957
[TBL] [Abstract][Full Text] [Related]
13. Skin manifestations and clinical features of drug reaction with eosinophilia and systemic symptoms: a retrospective multicentre study of 125 patients.
Lee JW; Lee SR; Kim MJ; Cho S; Youn SW; Yang MS; Kim SH; Kang HR; Kwon O
J Eur Acad Dermatol Venereol; 2022 Sep; 36(9):1584-1592. PubMed ID: 35342995
[TBL] [Abstract][Full Text] [Related]
14. Pediatric drug reaction with eosinophilia and systemic symptoms: A 12-year retrospective study in a tertiary center.
Chatproedprai S; Tiasiri N; Chantawarangkul K; Wananukul S
J Dermatol; 2024 Apr; 51(4):509-517. PubMed ID: 38214543
[TBL] [Abstract][Full Text] [Related]
15. Sulfasalazine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) with concomitant acute chikungunya virus infection: possible role of new viral trigger.
Sil A; Bhattacharjee MS; Chandra A; Pramanik JD
BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34642219
[TBL] [Abstract][Full Text] [Related]
16. Drug reaction with eosinophilia and systemic symptoms: A single center descriptive observational study.
Sandhu S; Neema S; Vashisht D; Venugopal R; Sengupta P; Radhakrishnan S
Dermatol Ther; 2021 Jan; 34(1):e14670. PubMed ID: 33314590
[TBL] [Abstract][Full Text] [Related]
17. Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study.
Kardaun SH; Sekula P; Valeyrie-Allanore L; Liss Y; Chu CY; Creamer D; Sidoroff A; Naldi L; Mockenhaupt M; Roujeau JC;
Br J Dermatol; 2013 Nov; 169(5):1071-80. PubMed ID: 23855313
[TBL] [Abstract][Full Text] [Related]
18. Drug reaction with eosinophilia and systemic symptoms: is cutaneous phenotype a prognostic marker for outcome? A review of clinicopathological features of 27 cases.
Walsh S; Diaz-Cano S; Higgins E; Morris-Jones R; Bashir S; Bernal W; Creamer D
Br J Dermatol; 2013 Feb; 168(2):391-401. PubMed ID: 23034060
[TBL] [Abstract][Full Text] [Related]
19. DRESS Syndrome.
Jain P; Garg S; Sharma VK; Maheshwari S
J Assoc Physicians India; 2019 Apr; 67(4):87-88. PubMed ID: 31299851
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of DRESS Syndrome in the Elderly: A Comparative Study of 55 Patients.
Bahloul E; Trimeche K; Sellami K; Hammami F; Hayder F; Chaabouni R; Amouri M; Masmoudi A; Mseddi M; Boudeya S; Turki H
Dermatitis; 2024; 35(1):55-60. PubMed ID: 37669109
[No Abstract] [Full Text] [Related]
[Next] [New Search]
